Radiotherapy risks are much higher for smokers

March 20, 2017, Cancer Research UK

Smokers treated for breast cancer have much higher risks than non-smokers of developing lung cancer or heart attack as a result of radiotherapy - according to a new study funded by Cancer Research UK and published today in the Journal of Clinical Oncology.

The study shows that for non-smokers the long-term risk of death from or - caused by radiation - is only 0.5 percent. But for smokers, this increases to around 5 percent.

These findings are based on a worldwide study by the Early Breast Cancer Trialists' Collaborative Group of the lung and heart radiation doses and risks among 40,781 women with in 75 randomised trials of radiotherapy.

Because modern breast radiotherapy techniques have improved and are now better at sparing the lungs and heart than those used in the trials, the researchers also reviewed recent literature so they could take into account how radiotherapy is better targeted today.

Dr Carolyn Taylor, radiation oncologist and lead author from the University of Oxford, said: "For non-smokers, the absolute risk of death from the side effects of modern radiotherapy is only about 0.5 percent, which is much less than the benefit. But for smokers, the risk is about 5 percent, which is comparable with the benefit.

"Stopping smoking at the time of radiotherapy will avoid most of the lung cancer and heart disease risk from radiotherapy, and has many other benefits."

Radiotherapy remains an important treatment for breast cancer and reduces the likelihood of dying from the disease. For most non-smokers or ex-smokers the benefits of radiotherapy will far outweigh any risks. But for some long-term continuing smokers, the risks may be greater than the benefits.

Dr Julie Sharp, Cancer Research UK's head of health information, said: "This research highlights that who smoke need to be offered help and support in order to try and quit to minimise any risks from their treatment. It's important to remember that modern day techniques have been refined and improved to make sure it is targeted and effective while reducing the risk of side-effects."

Explore further: Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer

More information: Taylor, C., et al Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials Journal of Clinical Oncology (2017) DOI: 10.1200/JCO.2016.72.0722

Related Stories

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer

February 16, 2017
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.

Some older cancer patients can avoid radiotherapy, study finds

January 28, 2015
Some older women with breast cancer could safely avoid radiotherapy, without harming their chances of survival, a study has shown.

Hodgkin lymphoma survivors at high risk of second cancers

March 13, 2017
Patients who are cured of Hodgkin lymphoma are at a high risk of developing a second type of cancer, particularly if they have a family history of the disease, a major new study reports.

Smoking can hamper common treatment for breast cancer

June 17, 2016
We know that individuals who smoke take major health risks. Now a new research study from Lund University in Sweden shows that common treatment for breast cancer works less well in patients who smoke, compared to non-smokers.

Increased risk of developing lung cancer after radiotherapy for breast cancer

April 7, 2014
Vienna, Austria: Women who have radiotherapy for breast cancer have a small but significantly increased risk of subsequently developing a primary lung tumour, and now research has shown that this risk increases with the amount ...

Smoking may increase risks for patients being treated for prostate cancer

January 27, 2015
Among patients with prostate cancer, those who smoke have increased risks of experiencing side effects from treatment and of developing future cancer recurrences, or even dying from prostate cancer. The findings, which are ...

Recommended for you

A new tactic for starving tumors

June 25, 2018
A tumor's goal is simple: to grow, grow, grow, by making more cancer cells. But that often means growing so fast that the oxygen supply gets scarce, at which point cells within the tumor start to suffocate. Without oxygen, ...

Immune profile for successful cancer immunotherapy discovered

June 25, 2018
In a new study published online June 25, 2018 in Nature Medicine, UC San Francisco researchers have identified a key biological pathway in human cancer patients that appears to prime the immune system for a successful response ...

'Embattled' breast cancer drugs could be revived by new discovery

June 25, 2018
More than 60 percent of breast cancer cases involve defects in the same biochemical chain of events within cancer cells—known as the PI3 kinase (PI3K) pathway—but efforts to develop therapies targeting this pathway have ...

Lethal prostate cancer treatment may benefit from combination immunotherapy

June 25, 2018
Researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy (BKI) released a study investigating the use of combination checkpoint immunotherapy in the treatment of a ...

New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

June 25, 2018
Survival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire study has shown.

Dying cancer cells make remaining glioblastoma cells more aggressive and therapy-resistant

June 21, 2018
A surprising form of cell-to-cell communication in glioblastoma promotes global changes in recipient cells, including aggressiveness, motility, and resistance to radiation or chemotherapy.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.